Nephrology · Ahmedabad
Diabetic Kidney Disease Treatment in Ahmedabad
Diabetic kidney disease is kidney damage caused by long-standing high blood sugar, and it is the single largest cause of kidney failure in India. Its first sign is small amounts of albumin in urine, which appear years before creatinine rises. Detected at that stage, progression can often be substantially slowed.
Reviewed by Dr. Pritish Shah, MBBS, MD (Internal Medicine), DrNB (Nephrology) — Senior Consultant Nephrologist, Apollo Hospitals International Limited, Ahmedabad.
Roughly one in three people with diabetes will develop kidney damage. What makes it treacherous is the sequence: albumin starts leaking into the urine quietly, and creatinine — the number most patients actually watch — stays perfectly normal for years while damage accumulates.
By the time creatinine rises, a significant share of filtering capacity is already gone. This is why a urine albumin test, which costs very little, is the most valuable kidney test a person with diabetes can do. Good sugar control alone is not enough; the kidney needs its own protection.
Recognising it
What to watch for
A falling insulin requirement in a long-standing diabetic is an underappreciated warning sign — failing kidneys clear insulin more slowly.
Investigation
Screening and diagnosis
Urine albumin-to-creatinine ratio, yearly
From the moment type 2 diabetes is diagnosed, and from five years after diagnosis in type 1. This is the single most important screening test, and the one most often skipped.
eGFR from serum creatinine
Performed at least annually alongside the urine test to track filtration over time.
Retinal examination
Diabetic eye and kidney damage usually travel together. Protein leak without any retinopathy raises the possibility of a different, non-diabetic kidney disease that needs separate investigation.
Blood pressure and HbA1c
Both are treatment targets in their own right, and both influence how quickly kidney damage advances.
Management
How diabetic kidney disease is treated
Modern treatment uses several agents that protect the kidney through different mechanisms, layered together.
SGLT2 inhibitors
Now a cornerstone of therapy. They reduce pressure inside the glomerulus and have been shown in large trials to slow kidney decline and reduce cardiovascular events, largely independently of their sugar-lowering effect.
ACE inhibitors or ARBs
First-line for reducing albumin leak and controlling blood pressure. Kidney function and potassium are checked shortly after starting or increasing the dose.
Non-steroidal MRA therapy
In selected patients with persistent albuminuria despite the above, this adds a further reduction in progression risk.
Glycaemic and blood pressure targets
An individualised HbA1c goal — tighter is not automatically better in advanced CKD — with blood pressure generally below 130/80 mmHg.
Cardiovascular risk reduction
People with diabetic kidney disease are far more likely to have a heart event than to reach dialysis. Lipid control and cardiac risk management are part of kidney care, not separate from it.
Medication safety review
Several diabetes drugs need dose adjustment or withdrawal as eGFR falls. Regular review prevents avoidable harm.
Book a kidney review if you have diabetes and
These situations change management and should not wait for the next annual check.
- You have never had a urine albumin test
- Your urine report mentions albumin, protein or microalbuminuria
- You have had diabetes for more than five years
- Your eGFR is below 60 or has dropped since your last test
- You have swelling, or your blood pressure has become harder to control
Questions
Diabetic Kidney Disease — frequently asked
Yes. Good control lowers the risk substantially but does not remove it. Blood pressure, duration of diabetes, genetics and albumin leak all contribute independently. Annual kidney screening is recommended regardless of how good your HbA1c is.
Please note: This page is general health information, not personal medical advice. Kidney disease varies significantly between individuals. Please consult a qualified nephrologist about your own reports before making any change to your treatment.